The many downsides and one upside of India’s clinical trials mess

  Hardly a week goes by when the term ˜clinical trial” is not in news, and unfortunately, in recent times, it’s been more for the wrong reasons. On January 9, Financial Times reported Novartis will face a criminal investigation for wrongful marketing practices of its popular blood pressure medicine Diovan. Then there was this detailed […]

The many downsides and one upside of India's clinical trials mess

  Hardly a week goes by when the term ˜clinical trial” is not in news, and unfortunately, in recent times, it’s been more for the wrong reasons. On January 9, Financial Times reported Novartis will face a criminal investigation for wrongful marketing practices of its popular blood pressure medicine Diovan. Then there was this detailed […]

When the Best Malaria Drug Starts Losing Power

Good things don’t last very long they say. Artemisinin, the plant-derived compound that has today become the best drug for malaria has started losing its effectiveness. Two new reports published today in Science and The Lancet show that the most deadly species of malaria parasite (Plasmodium falciparum) is becoming resistant to artemisinin-based drugs and the […]